Steven Cohen Viking Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 39,930 shares of VKTX stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,930Holding current value
$1.32 Million% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding VKTX
# of Institutions
451Shares Held
67.9MCall Options Held
7.72MPut Options Held
3.25M-
Vanguard Group Inc Valley Forge, PA10.2MShares$337 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$200 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$125 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$108 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$104 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.54B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...